US Stock MarketDetailed Quotes

COLL Collegium Pharmaceutical

Watchlist

31.780
-0.100-0.31%

Close Jul 12 16:00 ET

31.780
0.0000.00%

Post 16:53 ET

1.04BMarket Cap12.66P/E (TTM)

Collegium Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Total revenue

0.11%144.92M

22.17%566.77M

15.53%149.75M

7.63%136.71M

9.71%135.55M

72.85%144.77M

67.56%463.93M

373.72%129.62M

61.10%127.01M

48.96%123.55M

Operating revenue

0.11%144.92M

22.17%566.77M

15.53%149.75M

7.63%136.71M

9.71%135.55M

72.85%144.77M

67.56%463.93M

373.72%129.62M

61.10%127.01M

48.96%123.55M

Cost of revenue

-20.63%53.47M

-5.44%240.6M

-30.96%55.12M

-17.27%56.4M

-13.30%61.72M

91.08%67.37M

101.54%254.45M

178.21%79.83M

108.29%68.17M

117.67%71.19M

Gross profit

18.16%91.46M

55.70%326.17M

90.06%94.63M

36.49%80.31M

40.99%73.83M

59.60%77.4M

39.09%209.49M

3,835.11%49.79M

27.60%58.84M

4.23%52.36M

Operating expense

-20.45%41.98M

-9.63%159.21M

-13.38%32.94M

-8.01%35.3M

-7.42%38.19M

-9.80%52.78M

37.19%176.17M

34.81%38.03M

20.05%38.37M

21.95%41.25M

Selling and administrative expenses

-20.45%41.98M

-7.54%159.21M

-13.38%32.94M

-8.01%35.3M

-7.42%38.19M

-3.21%52.78M

44.74%172.19M

42.97%38.03M

25.75%38.37M

35.85%41.25M

Research and development costs

----

--0

----

-57.86%3.98M

--0

Operating profit

100.89%49.47M

401.10%166.96M

424.69%61.69M

119.93%45.01M

220.73%35.63M

345.90%24.63M

50.05%33.32M

139.79%11.76M

44.65%20.47M

-32.29%11.11M

Net non-operating interest income expense

31.20%-12.85M

-8.94%-67.72M

23.38%-14.98M

14.74%-16.23M

-0.45%-17.84M

-220.58%-18.68M

-196.00%-62.17M

-311.19%-19.55M

-272.36%-19.04M

-227.72%-17.76M

Non-operating interest income

63.34%4.49M

1,391.40%15.62M

318.99%4.3M

41,154.55%4.54M

80,440.00%4.03M

68,575.00%2.75M

8,625.00%1.05M

34,133.33%1.03M

266.67%11K

66.67%5K

Non-operating interest expense

-19.08%17.34M

31.84%83.34M

-6.29%19.28M

9.04%20.77M

23.10%21.86M

267.47%21.43M

200.81%63.21M

332.52%20.58M

272.36%19.05M

227.63%17.76M

Other net income (expense)

-23.5M

Special income (charges)

--0

---23.5M

--0

---23.5M

--0

-Less：Restructuring and merger&acquisition

----

--0

----

--0

----

-Less:Other special charges

----

--23.5M

--0

----

--23.5M

----

Income before tax

308.59%36.62M

362.53%75.73M

699.54%46.71M

1,909.99%28.78M

367.79%17.8M

-10.83%-17.56M

-754.98%-28.85M

79.96%-7.79M

-84.15%1.43M

-160.47%-6.65M

Income tax

6,900.76%8.91M

817.24%27.58M

2,594.93%14.77M

735.79%8.15M

429.21%4.79M

95.28%-131K

94.87%-3.85M

95.72%-592K

-1.61%975K

97.65%-1.46M

Net income

259.03%27.71M

292.60%48.16M

543.67%31.94M

4,415.10%20.63M

350.57%13.01M

-33.34%-17.43M

-134.96%-25M

71.24%-7.2M

-94.32%457K

-107.13%-5.19M

Net income continuous Operations

259.03%27.71M

292.60%48.16M

543.67%31.94M

4,415.10%20.63M

350.57%13.01M

-33.34%-17.43M

-134.96%-25M

71.24%-7.2M

-94.32%457K

-107.13%-5.19M

Minority interest income

Net income attributable to the parent company

259.03%27.71M

292.60%48.16M

543.67%31.94M

4,415.10%20.63M

350.57%13.01M

-33.34%-17.43M

-134.96%-25M

71.24%-7.2M

-94.32%457K

-107.13%-5.19M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

259.03%27.71M

292.60%48.16M

543.67%31.94M

4,415.10%20.63M

350.57%13.01M

-33.34%-17.43M

-134.96%-25M

71.24%-7.2M

-94.32%457K

-107.13%-5.19M

Basic earnings per share

268.63%0.86

293.24%1.43

557.14%0.96

6,000.00%0.61

353.33%0.38

-30.77%-0.51

-136.10%-0.74

71.23%-0.21

-95.65%0.01

-107.28%-0.15

Diluted earnings per share

239.22%0.71

274.32%1.29

495.24%0.83

5,200.00%0.53

326.67%0.34

-30.77%-0.51

-139.78%-0.74

71.23%-0.21

-95.45%0.01

-108.38%-0.15

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Total revenue	0.11%144.92M	22.17%566.77M	15.53%149.75M	7.63%136.71M	9.71%135.55M	72.85%144.77M	67.56%463.93M	373.72%129.62M	61.10%127.01M	48.96%123.55M
Operating revenue	0.11%144.92M	22.17%566.77M	15.53%149.75M	7.63%136.71M	9.71%135.55M	72.85%144.77M	67.56%463.93M	373.72%129.62M	61.10%127.01M	48.96%123.55M
Cost of revenue	-20.63%53.47M	-5.44%240.6M	-30.96%55.12M	-17.27%56.4M	-13.30%61.72M	91.08%67.37M	101.54%254.45M	178.21%79.83M	108.29%68.17M	117.67%71.19M
Gross profit	18.16%91.46M	55.70%326.17M	90.06%94.63M	36.49%80.31M	40.99%73.83M	59.60%77.4M	39.09%209.49M	3,835.11%49.79M	27.60%58.84M	4.23%52.36M
Operating expense	-20.45%41.98M	-9.63%159.21M	-13.38%32.94M	-8.01%35.3M	-7.42%38.19M	-9.80%52.78M	37.19%176.17M	34.81%38.03M	20.05%38.37M	21.95%41.25M
Selling and administrative expenses	-20.45%41.98M	-7.54%159.21M	-13.38%32.94M	-8.01%35.3M	-7.42%38.19M	-3.21%52.78M	44.74%172.19M	42.97%38.03M	25.75%38.37M	35.85%41.25M
Research and development costs	----	--0	--0	--0	--0	----	-57.86%3.98M	--0	--0	--0
Operating profit	100.89%49.47M	401.10%166.96M	424.69%61.69M	119.93%45.01M	220.73%35.63M	345.90%24.63M	50.05%33.32M	139.79%11.76M	44.65%20.47M	-32.29%11.11M
Net non-operating interest income expense	31.20%-12.85M	-8.94%-67.72M	23.38%-14.98M	14.74%-16.23M	-0.45%-17.84M	-220.58%-18.68M	-196.00%-62.17M	-311.19%-19.55M	-272.36%-19.04M	-227.72%-17.76M
Non-operating interest income	63.34%4.49M	1,391.40%15.62M	318.99%4.3M	41,154.55%4.54M	80,440.00%4.03M	68,575.00%2.75M	8,625.00%1.05M	34,133.33%1.03M	266.67%11K	66.67%5K
Non-operating interest expense	-19.08%17.34M	31.84%83.34M	-6.29%19.28M	9.04%20.77M	23.10%21.86M	267.47%21.43M	200.81%63.21M	332.52%20.58M	272.36%19.05M	227.63%17.76M
Other net income (expense)		-23.5M	0			-23.5M
Special income (charges)	--0	---23.5M	--0	--0	--0	---23.5M	--0	--0	--0	--0
-Less：Restructuring and merger&acquisition	----	--0	----	----	----	----	--0	----	----	----
-Less:Other special charges	----	--23.5M	--0	----	----	--23.5M	----	----	----	----
Income before tax	308.59%36.62M	362.53%75.73M	699.54%46.71M	1,909.99%28.78M	367.79%17.8M	-10.83%-17.56M	-754.98%-28.85M	79.96%-7.79M	-84.15%1.43M	-160.47%-6.65M
Income tax	6,900.76%8.91M	817.24%27.58M	2,594.93%14.77M	735.79%8.15M	429.21%4.79M	95.28%-131K	94.87%-3.85M	95.72%-592K	-1.61%975K	97.65%-1.46M
Net income	259.03%27.71M	292.60%48.16M	543.67%31.94M	4,415.10%20.63M	350.57%13.01M	-33.34%-17.43M	-134.96%-25M	71.24%-7.2M	-94.32%457K	-107.13%-5.19M
Net income continuous Operations	259.03%27.71M	292.60%48.16M	543.67%31.94M	4,415.10%20.63M	350.57%13.01M	-33.34%-17.43M	-134.96%-25M	71.24%-7.2M	-94.32%457K	-107.13%-5.19M
Minority interest income
Net income attributable to the parent company	259.03%27.71M	292.60%48.16M	543.67%31.94M	4,415.10%20.63M	350.57%13.01M	-33.34%-17.43M	-134.96%-25M	71.24%-7.2M	-94.32%457K	-107.13%-5.19M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	259.03%27.71M	292.60%48.16M	543.67%31.94M	4,415.10%20.63M	350.57%13.01M	-33.34%-17.43M	-134.96%-25M	71.24%-7.2M	-94.32%457K	-107.13%-5.19M
Basic earnings per share	268.63%0.86	293.24%1.43	557.14%0.96	6,000.00%0.61	353.33%0.38	-30.77%-0.51	-136.10%-0.74	71.23%-0.21	-95.65%0.01	-107.28%-0.15
Diluted earnings per share	239.22%0.71	274.32%1.29	495.24%0.83	5,200.00%0.53	326.67%0.34	-30.77%-0.51	-139.78%-0.74	71.23%-0.21	-95.45%0.01	-108.38%-0.15
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall